948 related articles for article (PubMed ID: 18469640)
1. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
2. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
4. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
5. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
Sakr Y; Reinhart K; Vincent JL; Sprung CL; Moreno R; Ranieri VM; De Backer D; Payen D
Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
[TBL] [Abstract][Full Text] [Related]
6. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
8. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock.
Mehta NJ; Khan IA; Gupta V; Jani K; Gowda RM; Smith PR
Int J Cardiol; 2004 May; 95(1):13-7. PubMed ID: 15159032
[TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
De Backer D; Creteur J; Silva E; Vincent JL
Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
[TBL] [Abstract][Full Text] [Related]
11. Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock.
Ataman K; Jehmlich M; Kock S; Neumann S; Leischik M; Filipovic Z; Hopf HB
Intensive Care Med; 2002 Aug; 28(8):1164-7. PubMed ID: 12185443
[TBL] [Abstract][Full Text] [Related]
12. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants.
Tourneux P; Rakza T; Abazine A; Krim G; Storme L
Acta Paediatr; 2008 Feb; 97(2):177-80. PubMed ID: 18177443
[TBL] [Abstract][Full Text] [Related]
14. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
Schmoelz M; Schelling G; Dunker M; Irlbeck M
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
[TBL] [Abstract][Full Text] [Related]
15. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
16. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
[TBL] [Abstract][Full Text] [Related]
17. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Lam SW; Bauer SR; Cha SS; Oyen LJ
Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
[TBL] [Abstract][Full Text] [Related]
18. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
19. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
20. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
